Jury to Start Deliberation in Two Vioxx Injury Cases (Vioxx lawsuit)
Jury to Start Deliberation in Two Vioxx Injury Cases
New York Times - ATLANTIC CITY, April 3 — After a month of testimony, the fourth Vioxx-related personal injury trial ended Monday with well-worn closing arguments from lawyers for Merck and for two men who say the company's drug Vioxx caused their heart attacks
Source: www.nytimes.com
Chronology of events surrounding Vioxx and other painkillers
Courier-Post - December 1998: Food and Drug Administration approves Pfizer Inc.'s Celebrex, the first Cox-2 inhibitor, to treat arthritis. Cox-2 drugs, part of the nonsteroidal anti-inflammatory (NSAID) drug class, inhibit the Cox-2 enzyme, which promotes
Source: www.courierpostonline.com
Wal-Mart program to build jobs, firms
Springfield News-Leader - Wal-Mart, often accused by critics of harming local businesses, announced Tuesday it plans to build more than 50 stores in struggling urban neighborhoods over the next two years to create jobs and help small establishments. Chief Executive Lee Scott
Source: www.springfieldnews-leader.com
Business briefs
Northwest Herald - WASHINGTON Treasury Secretary John Snow said Wednesday that the Chinese must be more aggressive in allowing their currency to rise in value against the U.S. dollar, and predicted a gradual improvement over the next year. Snow, testifying before a
Source: www.nwherald.com
Merck fined $9m in Vioxx lawsuit
Stockhouse Canada - Drugs firm Merck has been ordered to pay $9m (£5.1m) in damages to a US man after its Vioxx painkiller was found to have contributed to his heart attack. A New Jersey jury awarded the punitive damages to 77-year old John McDarby, almost a week after
Source: www.stockhouse.ca
0 Comments:
Post a Comment
<< Home